BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27486205)

  • 41. Smoking cessation in COPD causes a transient improvement in spirometry and decreases micronodules on high-resolution CT imaging.
    Dhariwal J; Tennant RC; Hansell DM; Westwick J; Walker C; Ward SP; Pride N; Barnes PJ; Kon OM; Hansel TT;
    Chest; 2014 May; 145(5):1006-1015. PubMed ID: 24522562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive Value of Combining Inflammatory Biomarkers and Rapid Decline of FEV
    Wang Y; Liao J; Zhong Y; Zhang C; Li X; Wang G
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2825-2833. PubMed ID: 31824147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New-onset COPD and Decline in Lung Function Among Wood Dust-Exposed Workers: Re-analysis of a 6-year Follow-up Study.
    Bolund ACS; Miller MR; Jacobsen GH; Sigsgaard T; Schlünssen V
    Ann Work Expo Health; 2018 Nov; 62(9):1064-1076. PubMed ID: 30165410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of smoking habits on pulmonary function. Cross-sectional and longitudinal studies in male subjects on medical check-up].
    Omori H; Morimoto Y
    Nihon Kokyuki Gakkai Zasshi; 2004 Apr; 42(4):306-12. PubMed ID: 15114846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emphysema Progression and Lung Function Decline Among Angiotensin Converting Enzyme Inhibitors and Angiotensin-Receptor Blockade Users in the COPDGene Cohort.
    Tejwani V; Fawzy A; Putcha N; Castaldi PJ; Cho MH; Pratte KA; Bhatt SP; Lynch DA; Humphries SM; Kinney GL; D'Alessio FR; Hansel NN;
    Chest; 2021 Oct; 160(4):1245-1254. PubMed ID: 34029566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of smoking and smoking cessation on longitudinal decline in pulmonary function.
    Burchfiel CM; Marcus EB; Curb JD; Maclean CJ; Vollmer WM; Johnson LR; Fong KO; Rodriguez BL; Masaki KH; Buist AS
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1778-85. PubMed ID: 7767520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study.
    Guerra S; Halonen M; Vasquez MM; Spangenberg A; Stern DA; Morgan WJ; Wright AL; Lavi I; Tarès L; Carsin AE; Dobaño C; Barreiro E; Zock JP; Martínez-Moratalla J; Urrutia I; Sunyer J; Keidel D; Imboden M; Probst-Hensch N; Hallberg J; Melén E; Wickman M; Bousquet J; Belgrave DC; Simpson A; Custovic A; Antó JM; Martinez FD
    Lancet Respir Med; 2015 Aug; 3(8):613-20. PubMed ID: 26159408
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
    Kamada T; Kaneko M; Tomioka H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for FEV
    Chen S; Wang C; Li B; Shi G; Li H; Zhang J; Gu Y; Zhou J; Song Y; Bai C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():435-442. PubMed ID: 28184155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short-term benefit of smoking cessation along with glycopirronium on lung function and respiratory symptoms in mild COPD patients: a retrospective study.
    Pezzuto A; Stellato M; Catania G; Mazzara C; Tonini S; Caricato M; Crucitti P; Tonini G
    J Breath Res; 2018 Aug; 12(4):046007. PubMed ID: 29967309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease.
    Kim J; Yoon HI; Oh YM; Lim SY; Lee JH; Kim TH; Lee SY; Lee JH; Lee SD; Lee CH
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1819-27. PubMed ID: 26379432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative Assessment of Mucociliary Clearance in Smokers with Mild-to-Moderate Chronic Obstructive Pulmonary Disease and Chronic Bronchitis from Planar Radionuclide Imaging Using the Change in Penetration Index.
    Fleming JS; Conway J; Bennett MJ; Tossici-Bolt L; Guy M; Blé FX; McCrae C; Carlsson M; Bondesson E
    J Aerosol Med Pulm Drug Deliv; 2019 Aug; 32(4):175-188. PubMed ID: 30848685
    [No Abstract]   [Full Text] [Related]  

  • 53. The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development.
    Allinson JP; Hardy R; Donaldson GC; Shaheen SO; Kuh D; Wedzicha JA
    Am J Respir Crit Care Med; 2016 Mar; 193(6):662-72. PubMed ID: 26695373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group.
    Tashkin DP; Altose MD; Connett JE; Kanner RE; Lee WW; Wise RA
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1802-11. PubMed ID: 8665038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Symptoms and lung function decline in a middle-aged cohort of males and females in Australia.
    Abramson MJ; Kaushik S; Benke GP; Borg BM; Smith CL; Dharmage SC; Thompson BR
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1097-103. PubMed ID: 27307725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relative contributions of emphysema and airway remodelling to airflow limitation in COPD: Consistent results from two cohorts.
    Tho NV; Ryujin Y; Ogawa E; Trang le TH; Kanda R; Goto K; Yamaguchi M; Nagao T; Lan le TT; Nakano Y
    Respirology; 2015 May; 20(4):594-601. PubMed ID: 25788016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relation of circulating YKL-40 to levels and decline of lung function in adult life.
    Guerra S; Halonen M; Sherrill DL; Venker C; Spangenberg A; Carsin AE; Tarès L; Lavi I; Barreiro E; Martínez-Moratalla J; Urrutia I; Sunyer J; Antó JM; Martinez FD
    Respir Med; 2013 Dec; 107(12):1923-30. PubMed ID: 23920328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma cathelicidin and longitudinal lung function in current and former smokers.
    Burkes RM; Astemborski J; Lambert AA; Brown TT; Wise RA; Kirk GD; Drummond MB
    PLoS One; 2019; 14(2):e0212628. PubMed ID: 30811465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank.
    Wain LV; Shrine N; Miller S; Jackson VE; Ntalla I; Soler Artigas M; Billington CK; Kheirallah AK; Allen R; Cook JP; Probert K; Obeidat M; Bossé Y; Hao K; Postma DS; Paré PD; Ramasamy A; ; Mägi R; Mihailov E; Reinmaa E; Melén E; O'Connell J; Frangou E; Delaneau O; ; Freeman C; Petkova D; McCarthy M; Sayers I; Deloukas P; Hubbard R; Pavord I; Hansell AL; Thomson NC; Zeggini E; Morris AP; Marchini J; Strachan DP; Tobin MD; Hall IP
    Lancet Respir Med; 2015 Oct; 3(10):769-81. PubMed ID: 26423011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.